Central Nucleus Amygdala Neurons

📖 Wiki Page

cell1391 wordssynced 2026-04-02

Central Nucleus Amygdala Neurons

Introduction

...

Central Nucleus Amygdala Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Central Nucleus Amygdala Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cell Types</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Amygdala, Central Nucleus</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>GABAergic Projection Neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Human, Mouse, Rat</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000878](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000878)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CRH</td>
<td>Stress response</td>
</tr>
<tr>
<td class="label">SST</td>
<td>Inhibitory modulation</td>
</tr>
<tr>
<td class="label">PKCδ</td>
<td>Fear conditioning</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Anxiety reduction</td>
</tr>
<tr>
<td class="label">PENK</td>
<td>Pain modulation</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Signal Type</td>
</tr>
<tr>
<td class="label">Basolateral Amygdala</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Parabrachial Nucleus</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>GABAergic/Peptidergic</td>
</tr>
<tr>
<td class="label">Thalamus ( medial )</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Prefrontal Cortex</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Brainstem nuclei</td>
<td>Mixed</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Signal Type</td>
</tr>
<tr>
<td class="label">Paraventricular Hypothalamus</td>
<td>CRH, GABA</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamus</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Periaqueductal Gray</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Nucleus Tractus Solitarius</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Ventral Tegmental Area</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Locus Coeruleus</td>
<td>CRH</td>
</tr>
</table>

Central Nucleus Amygdala Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Central Nucleus of the Amygdala (CeA) is a critical杏仁核输出结构，位于杏仁核复合体的中央部位。作为大脑恐惧、焦虑和自主神经控制的核心调节中枢，CeA协调对威胁的生理和行为反应，并与多种神经退行性疾病的发生发展密切相关。 [@ledoux2007]

Overview

Mermaid diagram (expand to render)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

[Cell Ontology (CL:0000878)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000878)
[OBO Foundry (CL:0000878)](http://purl.obolibrary.org/obo/CL_0000878)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Anatomy and Precise Location

Spatial Organization

The Central Nucleus of the Amygdala is located in the medial portion of the amygdala complex, approximately 2.5-3.0 mm lateral to the midline and 8-9 mm ventral to the cortical surface in adult humans. In rodents, the CeA lies approximately 2.0-2.5 mm caudal to the bregma. [@etkin2007]

Subdivisions

The CeA is divided into three anatomically and functionally distinct divisions:

Central Division (CeC): The primary output zone, containing mostly GABAergic projection neurons

Lateral Division (CeL): The main input-receiving region, subdivided into lateral (CeLL) and medial (CeLM) caps

Medial Division (CeM): Visceromotor output region with strong hypothalamic connections

Boundaries

Medial: Optic tract and tuberal hypothalamus
Lateral: Basolateral amygdala (BLA)
Dorsal: Stria terminalis and caudate nucleus
Ventral: Entorhinal cortex and presubiculum

Morphology and Cellular Characteristics

Neuronal Types

GABAergic Projection Neurons (80-90%)

The CeA contains primarily GABAergic neurons that project to downstream targets:

Protein kinase C delta (PKCδ)-positive neurons: Fear conditioning circuits
Somatostatin (SST)-positive neurons: Stress and anxiety modulation
Corticotropin-releasing hormone (CRH)-positive neurons: HPA axis activation
Proenkephalin (PENK)-positive neurons: Pain modulation

Neuropeptide Markers

Cellular Properties

Soma size: Medium (15-25 μm diameter)
Dendritic architecture: Spiny dendrites, moderate branching
Axonal projections: Extensive to hypothalamus and brainstem
Electrophysiology: Regular-spiking, some burst-firing

Molecular Mechanisms

Neurotransmitter Systems

GABAergic Signaling

GABA synthesis: GAD67 (GAD1) and GAD65 (GAD2)
GABA-A receptors: Fast inhibitory transmission
GABA-B receptors: Modulatory effects
Vesicular GABA transporter (VGAT)

Peptidergic Signaling

Corticotropin-Releasing Hormone (CRH)

Released during stress
Activates HPA axis
Modulates anxiety and fear
CRH receptor 1 (CRHR1) and CRHR2

Somatostatin (SST)

Inhibits growth hormone release
Modulates neuronal excitability
Anti-anxiety effects
SSTR1-SSTR5 receptors

Neuropeptide Y (NPY)

Anxiolytic properties
Reduces food intake
Anti-epileptic effects
Y1-Y5 receptors

Intracellular Signaling Pathways

Stress-Activated Pathways

CRH → CRHR1 → cAMP/PKA: Anxiety behavior
p38 MAPK: Stress-induced plasticity
JNK: Neuronal apoptosis

Neuroplasticity Pathways

ERK/MAPK: Long-term fear memory
mTOR: Synaptic protein synthesis
BDNF: Neuronal survival

Connectivity

Afferent Inputs

Efferent Outputs

Normal Function

Fear and Anxiety

Fear Conditioning

The CeA is essential for acquiring and expressing fear responses:

Acquisition: Associations between neutral and aversive stimuli
Expression: Freezing behavior and autonomic responses
Extinction: Learning that stimuli are safe
Generalization: Fear responses to similar stimuli

Anxiety Regulation

Threat detection: Rapid processing of potential danger
Risk assessment: Evaluation of environmental safety
Stress response: Coordination of behavioral and physiological reactions
Anxiety disorders: Dysregulated CeA activity

Autonomic Control

Cardiovascular Regulation

Heart rate modulation via vagus
Blood pressure regulation
Baroreceptor reflex integration

Respiratory Control

Breathing rate modulation
Stress-induced hyperventilation
Panic responses

Gastrointestinal Control

Gastric motility regulation
Stress-induced gastric ulceration
Appetite suppression

Pain Modulation

Stress-Induced Analgesia

Activation of endogenous opioid systems
Descending inhibition pathways
Interaction with PAG

Pain Facilitation

Enhanced pain sensitivity in stress
Chronic pain states
Headaches and migraines

Reward and Motivation

Feeding Behavior

Stress-induced anorexia
Leptin and ghrelin interaction
NPY modulation of appetite

Addiction

Drug reward processing
Withdrawal symptoms
Relapse mechanisms

Disease Vulnerability

Alzheimer's Disease

Behavioral and Psychological Symptoms

Anxiety: Present in 40-50% of AD patients
Agitation: CeA dysfunction contributes
Depression: Comorbid depression common

Autonomic Dysfunction

Cardiovascular dysregulation: Orthostatic hypotension
Sleep disturbances: Altered circadian rhythms
GI dysfunction: Constipation, dysphagia

Pathological Mechanisms

Amyloid deposition: In CeA neurons
Tau pathology: Neurofibrillary tangles
Cholinergic loss: Reduced acetylcholine
CRH dysregulation: HPA axis hyperactivity

Parkinson's Disease

Non-Motor Symptoms

Anxiety: 30-50% prevalence
Depression: Up to 50% of patients
Autonomic dysfunction: Orthostatic hypotension

Lewy Body Pathology

α-Synuclein: Deposited in CeA
Neuronal loss: Dopaminergic denervation
Circuit dysfunction: Basal ganglia-amygdala circuits

Amyotrophic Lateral Sclerosis (ALS)

Psychiatric Comorbidities

Anxiety: 20-30% prevalence
Depression: Emotional lability
Pseudobulbar affect: CeA involvement

Autonomic Failure

Respiratory dysfunction: Leading cause of death
Cardiovascular instability: Orthostatic hypotension
Swallowing difficulties: Dysphagia

Depression and Anxiety Disorders

Major Depressive Disorder

CRH hyperactivity: Elevated CRH in CeA
SST deficits: Reduced somatostatin
NPY reduction: Anxiety susceptibility

Anxiety Disorders

Generalized anxiety: CeA hyperactivity
Panic disorder: CeA fear circuits
Phobias: Conditioned fear responses
PTSD: Impaired extinction

Epilepsy

Temporal Lobe Epilepsy

Seizure propagation: CeA as relay
Fear memories: Affective components
Autonomic seizures: Ictal symptoms

Therapeutic Implications

Pharmacological Approaches

Anxiolytics

Benzodiazepines: GABA-A enhancement
SSRIs/SNRIs: Serotonin modulation
CRH antagonists: Stress reduction

Antidepressants

TCAs: Broad neurotransmitter effects
Ketamine: NMDA modulation
SSRIs: Plasticity enhancement

Emerging Therapies

Deep Brain Stimulation

Target: CeA or terminals
Effects: Anxiety reduction
Clinical trials: Ongoing

Gene Therapy

CRH reduction: Viral vectors
NPY enhancement: Anxiety treatment
Optogenetic approaches: Circuit manipulation

Research Directions

Circuit Mapping

Single-cell sequencing
Viral tracing
Optogenetic circuit analysis

Disease Mechanisms

Animal models of neurodegeneration
Biomarker development
Therapeutic targets

Therapeutic Development

Novel anxiolytics
Neuromodulation approaches
Cell replacement therapies
Amygdala Overview
Basolateral Amygdala Neurons
Fear Conditioning Mechanisms
Stress Response Pathways)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
Depression
Anxiety Disorders

Background

The study of Central Nucleus Amygdala Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[Allen Brain Atlas - Amygdala](https://portal.brain-map.org/)
[PubMed - Central Amygdala](https://pubmed.ncbi.nlm.nih.gov/?term=central+amygdala)
[Neuroscience - Amygdala Circuits](https://www.neuroscience.org/)

References

calhoon2015, Resolving the neural circuits of anxiety (2015)
davis1992, The role of the amygdala in fear and anxiety (1992)
etkin2007, Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia (2007)
gilpin2015, The central amygdala as an integrative hub for anxiety and alcohol use disorders (2015)
janak2015, From circuits to behaviour in the amygdala (2015)
ledoux2007, The amygdala (2007)
pare2004, New vistas on amygdala networks and behavior (2004)
sehlmeyer2011, Neural correlates of trait anxiety in fear conditioning (2011)
shin2010, The neurocircuitry of fear, stress, and anxiety disorders (2010)
tovote2015, Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16(6):317-331 (2015)

Pathway Diagram

The following diagram shows the key molecular relationships involving Central Nucleus Amygdala Neurons discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →